SREBF2 and endothelial dysfunction: In conclusion, our study uncovers a novel mechanism by which disturbed flow drives endothelial dysfunction through promoting 12/15-LOX via a SREBP2-dependent pathway, which orchestrates the production of pro-inflammatory PUFA metabolites.